AHCA Pulled from House Vote

American Health Care Act on chalkboardThis past month, there has been a roller coaster of events, regarding the future of our country’s healthcare system, as the White House and House of Representatives scrambled to pass a revised version of the American Health Care Act. However, despite the chaos that ensued in the final weeks before the bill was to be voted on, the Affordable Care Act is still in place, and the future of healthcare is largely up in the air. Here is some information about the AHCA vote that didn’t happen, and what medical companies may expect in the future…

The tightrope walk through congress

Despite the animosity that the Republican congressional majority has for the Affordable Care Act, it is its own largest obstacle in getting rid of it. The problem that government leaders have found is that the different wings of their party are separated by far more ideology than they realized before they controlled each branch of government. Namely, moderate Republicans found that the AHCA would push too many people off of insurance, and conservative Republicans of the Freedom Caucus who felt that too much of the ACA would exist in the current rendition of the bill.

In the final days before the House of Representatives were scheduled to vote on the act, the White House and Congressional leaders hurriedly revised aspects of the bill to eliminate further aspects of the ACA, in order to win over members of the Freedom Caucus. However, the vote count still came up short, causing Rep. Paul Ryan to withdraw the scheduled vote.

Medical companies still in limbo

Despite failing to bring the bill to a vote this time around, Congressional Republicans have stated that they plan to draft a new plan and are still dedicated to repealing and replacing the ACA. This is of particular concern for insurance companies, and other medical businesses, because of the uncertainty that it places on the industry. Before the bill was voted on, Aetna announced that it wouldn’t sell new plans based on the Affordable Care Act and will reduce its participation in the American insurance marketplace until regulation has been decided upon. Instead of having a solid answer in March, the industry is still in the same limbo that it was in before.